PROTOCOL


 Endometrium 10 – 2,000 cells on the day of plating (96- 100 3 Paclitaxel, 5-FU, carboplatin, doxorubicin, everolimus 2019 72
 well format)
 Endometrium 1 <70 µm Unknown 0 6 Paclitaxel, carboplatin, mitomycin C 2018 54
 Esophagus Unknown – Unknown 20 6 MK-1775, camptothecin, AZD7762, taselisib, linsitinib, 2018 39
 afatinib, OSI-027, crizotinib, PD-173074, palbociclib,
 navitoclax, axitinib, SB216763, doramapimod, Nutlin-3a,
 MK-2206, BMS-754807, trametinib, dabrafenib, olaparib,
 sapatinib, alpelisib, SCH772984, S-crizotinib
 Head and neck 2 <70 µm 500–1,000 5 5 Irradiation, cisplatin, carboplatin, cetuximab, alpelisib, 2019 19
 everolimus, nutlin, niraparib, AZD4547
 Liver 2 >40 µm, <70 µm 600–800 2 6 Cisplatin, dabrafenib, olaparib, CH5424802, AZD8931, 2017 47
 taselisib, LGK974, EMD-1214063, LY2109761, GSK126,
 deltarasin, KU-55933, BIBR-1532, vorinostat, axitinib,
 Nutlin-3a, PD-173074, MK-2206, PD-0332991, lapatinib,
 SCH772984, OSI-027, BIRB 0796, 5-FU, dasatanib,
 sorafenib, doxorubicin, gemcitabine, trametinib
 Liver 3 – 6,000 cells on the day of plating 100 11 Nilotinib, crizotinib, XL147, afatinib, erlotinib, AUY922, 2018 70
 NVP-TAE684, everolimus, bortezomib, geﬁtinib, brivanib,
 imatinib, olaparib, SGX-523, sorafenib, GSK690693,
 saracatinib, selumetinib, MK-2206, linsitinib, palbociclib,
 dasatinib, tandutinib, OSI-930, regorafenib, oxaliplatin,
 ENMD-2076, tivozanib, 5-FU, vemurafenib, barasertib,
 AZD6482, AZD7762, rismodegib, KU-60019, rigosertib,
 MK1775, lapatinib, CP-466722, LY2157299, GDC-0980,
 dacomitinib, irinotecan, trametinib, ruxolitinib, LY2109761,
 Torin 2, CHIR-99021, FR-180204, LGK-974, SCH772984,
 SB265610, CCT251455, CCT252422, CCT241736
 Liver 3 – Unknown Unknown 4 Methotrexate, busulfan, thioguanine, mercaptopurine, 2019 56
 mechlorethamine hydrochloride, allopurinol, dactinomycin,
 chlorambucil, thiotepa, melphalan hydrochloride,
 triethylenemelamine, altretamine, aminolevulinic acid
 hydrochloride, 5-FU, plicamycin, pipobroman,
 cyclophosphamide, mitomycin, ﬂoxuridine, hydroxyurea,
 uracil mustard, mitotane, dacarbazine, methoxsalen,
 vinblastine sulfate, cytarabine hydrochloride, thalidomide,
 vincristine sulfate, megestrol acetate, triﬂuridine,
 procarbazine hydrochloride, lomustine, daunorubicin
 hydrochloride, streptozocin, arsenic trioxide, azacitidine,
 cladribine, ifosfamide, cisplatin, tretinoin, teniposide,
 doxorubicin hydrochloride, bleomycin sulfate, paclitaxel,
 decitabine, bendamustine hydrochloride, etoposide,
 dexrazoxane, tamoxifen citrate, pentostatin, sirolimus,
 carboplatin, valrubicin, idarubicin hydrochloride, epirubicin
 hydrochloride, oxaliplatin, mitoxantrone, amifostine,
 ﬂudarabine phosphate, temozolomide, imiquimod,
 carmustine, clofarabine, vinorelbine tartrate, topotecan
 hydrochloride, gemcitabine hydrochloride, irinotecan
 hydrochloride, docetaxel, temsirolimus, vorinostat,
 estramustine phosphate sodium, capecitabine, exemestane,
 geﬁtinib, erlotinib hydrochloride, fulvestrant, anastrozole,
 letrozole, celecoxib, zoledronic acid
 Lung 0 – 600–800 5 5 Paclitaxel, methotrexate, crizotinib, cisplatin, Nutlin-3a, 2019 48
 erlotinib, alpelisib, geﬁtinib
 NATURE PROTOCOLS


 Table continued


NATURE PROTOCOLS | VOL 15 | OCTOBER 2020 | 3380–3409 | www.nature.com/nprot

Table 2 (continued)
 Organ Days after Filter size Number per well (384-well format, % (vol/vol) Days of drug Therapies tested Year Reference
 NATURE PROTOCOLS


 splitting unless otherwise speciﬁed) BME/Matrigel/ exposure
 Geltrex


 Lung 10–14 – 2,000 cells on the day of plating (96- 75 6 Crizotinib, erlotinib, olarparib, docetaxel 2019 49
 well format)
 Lung 1 <70 µm or Unknown 0 6 GDC-0068, erlotinib, osimertinib, rociletinib, lapatinib, 2019 67
 <100 µm afatinib, ARRY-380, varlitinib, binimetinib, AZD6244, NVP-
 BKM120, idelalisib, GDC-0980, dabrafenib, vemurafenib,
 sorafenib, nilotinib, ponatinib, DCC-2036, ceritinib,
 crizotinib, entrectinib, danusertib, obatoclax, ibrutinib, PAC-
 1, PHA-793887, dinaciclib, GSK126, entinostat,
 panobinostat, belinostat, PCI-34051, tubastatin A,
 vismodegib, tivantinib, foretinib, ganetespib, AGI-5198,
 vorasidenib, AGI-6780, OSI-906, BMS-754807, ruxolitinib,
 everolimus, MLN-4924, olaparib, tandutinib, volasertib,
 bortezomib, AZD4547, RO-4929097, AZD0530, BX-795,


NATURE PROTOCOLS | VOL 15 | OCTOBER 2020 | 3380–3409 | www.nature.com/nprot
 Nutlin-3, brivanib, sunitinib, regorafenib, lenalidomide,
 gemcitabine, carﬁlzomib, dexamethasone, methotrexate,
 etoposide, melphalan, temozolomide, mitomycin C, 5-FU,
 tacrolimus, rapamycin, elesclomol, alvespimycin, vindesine,
 leﬂunomide, decitabine, carboplatin, mycophenolic acid,
 paclitaxel
 Lung, ovarian 3 – 2,500 cells on the day of plating (96- 2 3 (+3 d recovery Paclitaxel, carboplatin, doxorubicin, olaparib, BKM120, MK- 2017 74
 well format) afterward before the 5108, belinostat, AZD2014, AZD5363, temsirolimus,
 readout was azacytidine, decitabine, dasatinib, cyclopamine, DAPT,
 performed) NSC23766, ICG-001
 Ovarian 0 <70 µm 750–1,000 2 5 Alpelisib, adavosertib, AZD8050, carboplatin, gemicitabine, 2019 50
 MK-2206, niraparib, Nutlin-3a, paclitaxel, pictilisib
 Pancreas 0 – 600–800 10 5 5-FU, gemcitabine, nab-paclitaxel, oxalplatin, irinotecan, 2018 11
 selumetinib, afatinib, bortezomib, lapatinib, sunitinib,
 olaparib, Nutlin-3, MK-2206, KU-55933, everolimus,
 celecoxib, ruxolitinib, SB5225334, SGI-1776, OSI-420,
 TPCA-1, LY2874455, SF1670, K-ras(G12C) inhibitor 9,
 WIKI4, disulfuram
 Pancreas 5 – – 6.7 3 Gemcitabine, 5-FU, paclitaxel, vinblastine, MK2206, OSI- 2019 58
 906, GDC0449, OSI-027, lapatinib, trametinib, LGK974,
 olaparib, vorinostat, BMS-708163, GDC0032, MK-1775,
 AZD7762, Nutlin-3a, erlotinib, ABT-263, sorafenib,
 SCH772984, PD-0332991, PF-02341066, BMS-754807,
 cisplatin, SN-38
 Prostate – – 5,000 100 4 Ezalutamide, everolimus, BKM-120 2014 21
 Stomach 1 – 600–800a 50 6 5-FU, cisplatin, olaparib 2018 52
 Stomach 2 – 750–1,000 100 1–3 5-FU, oxaliplatin, irinotecan, epirubicin, docetaxel 2019 53
 Colon 4 – 100 66 6 5-FU, oxaliplatin, SN-38 2019 32
 a
 Assuming 40 µl was dispensed per well. NOS, not otherwise speciﬁed; 5-FU, ﬂuorouracil.
